Europe Veterinary Orthopedic Implants Market Size & Share 2025 to 2034
Market Size by Product, by Application, by Animal Type, by End Use, Forecast.
Download Free PDF
Market Size by Product, by Application, by Animal Type, by End Use, Forecast.
Download Free PDF
Starting at: $1,950
Base Year: 2024
Companies Profiled: 15
Tables & Figures: 110
Countries Covered: 7
Pages: 128
Download Free PDF
Europe Veterinary Orthopedic Implants Market
Get a free sample of this report
Europe Veterinary Orthopedic Implants Market Size
The Europe veterinary orthopedic implants market size was estimated at USD 189.6 million in 2024. The market is expected to grow from USD 202.1 million in 2025 to USD 410.3 million in 2034, at a CAGR of 8.2%, according to the latest report published by Global Market Insights Inc.
Europe Veterinary Orthopedic Implants Market Key Takeaways
Market Size & Growth
Regional Dominance
Key Market Drivers
Challenges
Opportunity
Key Players
The market is witnessing rapid growth due to the increasing incidence of bone fractures, ligament injuries, and joint diseases in pets. Pet ownership has been on the rise in European nations, resulting in a larger population of animals in need of advanced medical treatment. For instance, according to the European Pet Food Industry Federation (FEDIAF) “Facts & Figures 2025” report, which is based on data from 2023, pet ownership has grown to 139 million European households, equaling 49% of households owning a companion animal. Such a high pet population in the region increases the demand for various pet care services, including surgeries, thereby driving the market growth.
Veterinary orthopedic implants are medical devices used for correcting fractures, stabilizing joints, and assisting bone healing in animals. Such implants consist of bone plates, screws, pins, wires, and prosthetic joints customized to resist the biomechanical stresses of various species. The Europe market is influenced by the presence of major players such as DePuy Synthes (Johnson & Johnson), B. Braun VetCare, Movora (Vimian Group AB), Arthrex Vet Systems, and Integra LifeSciences. They shape the market through innovation in implant materials and design, provision of training and surgical assistance to veterinarians, and growing distribution networks in Europe.
During 2021-2023, Europe veterinary orthopedic implants market witnessed steady growth, growing from USD 159.1 million to USD 178.1 million in 2023. From 2021 to 2023, one of the key trends in the Europe market was the increasing use of advanced fixation devices such as locking plates, intramedullary nails, and patient-specific 3D-printed implants for pet animals. This shift was driven by the growing demand for higher success rates in fracture repair, faster recovery, and the ability to treat complex cases in dogs, cats, and equines. Veterinary clinics in Europe increasingly made investments in advanced surgical equipment and implants, with the backing of increased pet healthcare spending and insurance. This trend helped the market by growing the scope of conditions that could be treated, enhancing surgical success, and boosting pet owners' confidence in undergoing complex orthopedic procedures, thus raising the overall volume of implant adoption.
Veterinary orthopedic implants are artificial components used in veterinary medicine to restore function to fractured bones or replace damaged joints, bones or cartilage. These implants are made of metals such as titanium or stainless steel. The implants serve to manage fractures, joint disorders, and other musculoskeletal afflictions in animals.
Europe Veterinary Orthopedic Implants Market Trends
Europe Veterinary Orthopedic Implants Market Analysis
The Europe market was valued at USD 159.1 million and USD 168 million in 2021 and 2022, respectively. The market size reached USD 189.6 million in 2024, growing from USD 178.1 million in 2023.
Based on the product, the Europe market is divided into implants and instruments. The implants segment is further sub-segmented into plates, joint implants, bone screws and anchors, pins and wires, and other implants. The implants segment dominated the market in 2024 with USD 134.9 million and is poised to capture a market size of USD 296.4 million by 2034.
Based on animal type, the Europe veterinary orthopedic implants market is categorized into small and medium animals and large animals. The small and medium animals’ segment is further categorized into dogs, cats, and other small and medium animals. The small and medium animals segment dominated the market in 2024 with a market share of 72.3%. The large animal’s segment, on the other hand, accounted for a share of 27.7% in the Europe market. Livestock animals such as pigs, sheep, and goats play a crucial role in agriculture and the economy. The increasing demand for meat, dairy, and wool products has led to intensified livestock farming practices. This intensification can result in a higher incidence of orthopedic issues due to factors such as confined spaces and rapid growth rates, thereby driving the need for veterinary orthopedic interventions.
Based on the application, the Europe veterinary orthopedic implants market is categorized into Tibial Plateau Leveling Osteotomy (TPLO), Tibial Tuberosity Advancement (TTA), joint replacement, trauma, and other applications. The joint replacement segment is further sub-categorized into hip replacement, knee replacement, elbow replacement, and ankle replacement. The joint replacement segment held a share of 28% in 2024 and is poised to grow at a considerable rate of 8.8% during the forecast year.
Based on the end use, the Europe veterinary orthopedic implants market is categorized into veterinary hospitals and clinics and other end users. The veterinary hospitals and clinics segment accounted for revenue of USD 163.7 million in 2024 and is anticipated to grow at a CAGR of 8.4% over the analysis period.
The Germany veterinary orthopedic implants market was valued at USD 34.4 million and USD 36.2 million in 2021 and 2022, respectively. The market size reached USD 40.8 million in 2024, growing from USD 38.4 million in 2023.
France is witnessing robust growth in the Europe veterinary orthopedic implants market and is anticipated to grow at a CAGR of 9.1% between 2025 - 2034.
UK held a significant share of 16.5% in Europe veterinary orthopedic implants industry.
Europe Veterinary Orthopedic Implants Market Share
The veterinary orthopedic implants market is witnessing substantial growth, fueled by the increasing prevalence of orthopedic conditions in companion and farm animals, a surge in pet ownership, and the rising demand for advanced surgical procedures. This market encompasses leading global healthcare companies, medical device manufacturers, and veterinary-focused firms delivering innovative orthopedic solutions. The top 5 market players in the Europe market, including DePuy Synthes (Johnson & Johnson), B. Braun VetCare, Movora (Vimian Group AB), Arthrex Vet Systems, and Integra LifeSciences, account for ~52.5% of the market. These industry players undertake strategic initiatives, such as product launches and approvals, assisting them in sustaining market competition.
Further, technological advancements such as 3D printing, customized implant design, and minimally invasive surgical techniques are revolutionizing veterinary orthopedics. Additionally, growing veterinary infrastructure, strategic collaborations with veterinary hospitals, and investments in research and development are driving market expansion. The focus on sustainability, affordability, and enhanced implant biocompatibility ensures continued innovation to meet the evolving needs of veterinary surgeons and animal healthcare providers.
Europe Veterinary Orthopedic Implants Market Companies
Few of the prominent players operating in the Europe veterinary orthopedic implants industry include:
DePuy Synthes, a subsidiary of Johnson & Johnson, is a key player in the veterinary orthopedic implants market, accounting for ~31.8% of the market share. The company offers a wide range of implants and instruments designed to address fractures, joint issues, and musculoskeletal conditions in companion animals. Strategic partnerships with veterinary hospitals and continued investments in research and development solidify its leadership position, supporting the development of next-generation implants tailored to veterinary needs.
Movora, a subsidiary of Vimian Group AB, operates exclusively within the veterinary orthopedic implants market, offering a dedicated range of implants and surgical instruments. The company focuses on developing innovative orthopedic solutions, including advanced joint replacement systems, plates, and fixation devices tailored specifically for companion animals. Movora invests heavily in research, ensuring product quality, durability, and surgical precision.
B. Braun VetCare holds a strong position in the Europe market by offering a wide range of high-quality plates, screws, and surgical instruments tailored for small and medium animals. The company’s focus on precision-engineered implants and comprehensive surgical kits ensure reliable outcomes, which strengthens surgeon preference. Their emphasis on innovation and safety has helped maintain a competitive edge in the growing orthopedic segment.
Collective market share in 2024 is ~31.8%
Collective market share in 2024 is Market Share 52.5%
Europe Veterinary Orthopedic Implants Industry News:
The Europe veterinary orthopedic implants market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By Animal Type
Market, By Application
Market, By End Use
The above information is provided for the following countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →